Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Thomas Schluep

Showing results (1-10 of 33) with videos related to

Pageof 4
Sort By:
Journal of Drug Delivery|April 13, 2012
Cyclodextrin-containing polymers: versatile platforms of drug delivery materialsJeremy D Heidel, Thomas Schluep
Gastroenterology|December 9, 2024
ReplyVirginia C Clark, Pavel Strnad, Thomas Schluep
Current Bioactive Compounds|November 15, 2011
CRLX101 (formerly IT-101)-A Novel Nanopharmaceutical of Camptothecin in Clinical DevelopmentCissy Young, Thomas Schluep, Jungyeon Hwang, et al.
International Journal of Nanomedicine|November 11, 2008
Alpha-methylprednisolone conjugated cyclodextrin polymer-based nanoparticles for rheumatoid arthritis therapyJungyeon Hwang, Kathleen Rodgers, James C Oliver, et al.
Cancer Chemotherapy and Pharmacology|September 1, 2005
Pharmacokinetics and biodistribution of the camptothecin-polymer conjugate IT-101 in rats and tumor-bearing miceThomas Schluep, Jianjun Cheng, Kay T Khin, et al.
Nanomedicine : Nanotechnology, Biology, and Medicine|October 20, 2009
Tumor-associated macrophages are predominant carriers of cyclodextrin-based nanoparticles into gliomasDarya Alizadeh, Leying Zhang, Jungyeon Hwang, et al.
Gastroenterology|April 26, 2025
PNPLA3 Inhibition and Cardiometabolic Risk: Reassessing Dyslipidemia and ASCVD ConcernsShicheng Guo, Eric Garcia-Medel, Thomas Schluep, et al.
Bioconjugate Chemistry|November 16, 2006
A solvent-free method for isotopically or radioactively labeling cyclodextrins and cyclodextrin-containing polymersRyan K Zeidan, Stacey A Kalovidouris, Thomas Schluep, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 2, 2009
Polymeric tubulysin-peptide nanoparticles with potent antitumor activityThomas Schluep, Paula Gunawan, Ling Ma, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 15, 2006
Preclinical efficacy of the camptothecin-polymer conjugate IT-101 in multiple cancer modelsThomas Schluep, Jungyeong Hwang, Jianjun Cheng, et al.
Pageof 4

Showing results (1-10 of 33) with videos related to

Sort By:
Pageof 4
Journal of Drug Delivery|April 13, 2012
Cyclodextrin-containing polymers: versatile platforms of drug delivery materialsJeremy D Heidel, Thomas Schluep
Gastroenterology|December 9, 2024
ReplyVirginia C Clark, Pavel Strnad, Thomas Schluep
Current Bioactive Compounds|November 15, 2011
CRLX101 (formerly IT-101)-A Novel Nanopharmaceutical of Camptothecin in Clinical DevelopmentCissy Young, Thomas Schluep, Jungyeon Hwang, et al.
International Journal of Nanomedicine|November 11, 2008
Alpha-methylprednisolone conjugated cyclodextrin polymer-based nanoparticles for rheumatoid arthritis therapyJungyeon Hwang, Kathleen Rodgers, James C Oliver, et al.
Cancer Chemotherapy and Pharmacology|September 1, 2005
Pharmacokinetics and biodistribution of the camptothecin-polymer conjugate IT-101 in rats and tumor-bearing miceThomas Schluep, Jianjun Cheng, Kay T Khin, et al.
Nanomedicine : Nanotechnology, Biology, and Medicine|October 20, 2009
Tumor-associated macrophages are predominant carriers of cyclodextrin-based nanoparticles into gliomasDarya Alizadeh, Leying Zhang, Jungyeon Hwang, et al.
Gastroenterology|April 26, 2025
PNPLA3 Inhibition and Cardiometabolic Risk: Reassessing Dyslipidemia and ASCVD ConcernsShicheng Guo, Eric Garcia-Medel, Thomas Schluep, et al.
Bioconjugate Chemistry|November 16, 2006
A solvent-free method for isotopically or radioactively labeling cyclodextrins and cyclodextrin-containing polymersRyan K Zeidan, Stacey A Kalovidouris, Thomas Schluep, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 2, 2009
Polymeric tubulysin-peptide nanoparticles with potent antitumor activityThomas Schluep, Paula Gunawan, Ling Ma, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 15, 2006
Preclinical efficacy of the camptothecin-polymer conjugate IT-101 in multiple cancer modelsThomas Schluep, Jungyeong Hwang, Jianjun Cheng, et al.
Pageof 4